- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
CDC Report Underscores Impact of Early Diagnosis and Innovation on Cancer Survival
Two out of three people with metastatic disease survive 5 years or more, the report shows. The authors hope the data can help researchers develop better cancer control programs.
Two out of 3 Americans with invasive cancer—the kind that has spread to nearby healthy tissue—are living 5 years or more after diagnosis, according to a new report from the CDC.
Data have shown that early detection and innovation in cancer treatment have increased the number of cancer survivors over the last several years, and the new report, published in the CDC’s Morbidity and Mortality Weekly Report, shows that even patients with invasive cancer have encouraging survival rates.
To reach these numbers, CDC researchers looked at the number of cancer cases reported to U.S. cancer registries in 2011, the year of the most recently available data. That year saw 1,532,066 invasive cancer cases, or 451 cases per 100,000 people.
The CDC reports that the most common cancer sites were prostate, breast, lung, and colon, and rectum. The 5-year survival rates for those cancers came out to 97% for prostate cancer, 88% for breast cancer, 63% for colorectal cancer and 18% for lung cancer. While the rates were relatively even among men and women, racial disparities existed; 65% of white people had a 5-year relative survival rate, and 60% of black people had the same.
Link to the TIME article:
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More
